Concentra Group Holdings Parent, Inc.

Concentra Expands Florida Footprint with New Daytona Beach Medical Center

Concentra opened its first Volusia County medical center in Daytona Beach, Florida, located at 2200 W. International Speedway near Interstate 95, expanding occupational health access for employers across the Greater Daytona region. The center provides work injury care, physical therapy, DOT physical examinations, pre-placement physicals, medical surveillance, respirator fit testing, and drug and alcohol screening, with Concentra Telemed available for eligible minor injuries; a ribbon-cutting is scheduled for Sept. 16. Companywide, Concentra serves more than 200,000 employer customers including 95% of the Fortune 500, supporting roughly 54,000 patients per business day across 633 occupational health centers and 415 onsite clinics as of June 30, 2026.

•1mo ago

Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

Concentra appointed Dr. Jill Rosenthal as Chief Medical Officer, effective Jan. 1, 2027, succeeding the retiring Dr. John Anderson. Dr. Rosenthal returns to Concentra after 16 years as CMO at Zenith Insurance Company and currently serves as president of the American College of Occupational and Environmental Medicine. She will join the company on Sept. 1 to lead national clinical strategy, physician leadership, and medical innovation initiatives.

•2mo ago

Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition

Concentra completed the acquisition of four Minnesota Occupational Health (MOH) medical centers in the Twin Cities, immediately rebranding them under the Concentra name. The transaction expands Concentra's presence in Minnesota to eight total centers, integrating local care teams with the company’s national clinical and operational resources. The company plans to invest in enhancing the care experience across the acquired centers, including significant improvements to establish the St. Paul/Midway location as a regional flagship.

•2mo ago

CON: 10-Q · periodic report

Concentra Group Holdings Parent (NYSE: CON) reported Q2 2026 revenue of $606.0 million, up 10.0% year over year, with net income attributable to the Company of $65.3 million versus $44.6 million a year ago and EPS of $0.51 versus $0.35. Six-month revenue rose 11.8% to $1,175.6 million with EPS of $0.90 versus $0.65. Growth was driven by both volume and price: patient visits rose 2.6% to 3.61 million, revenue per visit increased 4.6% to $152.67 on higher workers' compensation fee-schedule reimbursement and employer services rates, and Adjusted EBITDA climbed 22.5% to $140.9 million with margin expanding to 23.3% from 20.9%. Free cash flow more than doubled to $121.0 million in the quarter. The company continued returning capital, paying $0.0625/share quarterly dividends ($16.0 million in H1) and repurchasing $25.9 million of stock in the first half, leaving $54.1 million on its $100 million authorization; a new $0.0625 dividend was declared August 5, 2026. Balance sheet strength improved with $158.0 million cash, $430.2 million revolver availability, and leverage of 2.99x versus a 6.5x covenant. Watch items include consolidated data breach lawsuits and an inherited DOJ False Claims Act investigation into physical therapy billing (originating at former parent Select, which Concentra is not a defendant in but is cooperating with); management states neither is expected to have a material impact but outcomes remain unpredictable.

SEC 10-Q•2mo ago

Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2026 and Raises FY 2026 Guidance

Concentra reported solid second-quarter results with revenue rising 10% year-over-year to $606.0 million and net income increasing 46.5% to $67.3 million. Driven by the strong performance, the company raised its full-year 2026 guidance, now projecting revenue between $2.325 billion and $2.375 billion and Adjusted EBITDA of $485 million to $495 million. The Board also declared a $0.0625 per share cash dividend and announced a leadership transition effective November 1, appointing Matt DiCanio as CEO while current CEO Keith Newton becomes Executive Chairman.

•2mo ago

Concentra Expands into Idaho with Opening of Boise Medical Center

Concentra opened its first medical center in Boise, Idaho, expanding its footprint into the state's growing market. The facility in Federal Way Plaza provides occupational health services, with a second location planned for nearby Meridian later this year. Nationally, Concentra operates 632 centers and 411 onsite clinics across 47 states, serving approximately 54,000 patients daily.

•3mo ago

Concentra Expands Near Kansas City International Airport with New Medical Center

Concentra opened a new medical center in Kansas City, Missouri, located near Kansas City International Airport, to expand access to occupational health services in the region. The facility will offer comprehensive care including injury treatment, physical therapy, drug testing, and DOT physicals, supported by the company's Concentra Telemed platform. This expansion marks a continued investment in the Midwest's business and transportation hub, providing employers with resources to manage workforce health and regulatory compliance.

•3mo ago

Concentra Expands Arizona Presence with New Goodyear Medical Center

Concentra opened a new medical center in Goodyear, Arizona, expanding its Arizona footprint to 17 locations to serve employers and employees in the West Valley. The facility offers occupational health services including work injury care, physical therapy and drug testing, targeting industries such as logistics, manufacturing and construction. As of March 31, 2026, the company operates 632 occupational health centers and 411 onsite clinics across 47 states, serving approximately 54,000 patients daily.

•4mo ago

Concentra Group Holdings Parent, Inc. Announces Results for Its First Quarter Ended March 31, 2026, Cash Dividend, and Raised FY 2026 Guidance

Concentra reported Q1 2026 revenue of $569.6 million, up 13.7% year-over-year, with net income rising 28.7% to $52.3 million. Adjusted EBITDA reached $120.7 million, a 17.6% increase from $102.7 million in Q1 2025, while Free Cash Flow turned positive at $9.9 million. The company raised its full-year 2026 guidance, now expecting revenue between $2.275 billion and $2.375 billion, with Adjusted EBITDA of $460 million to $480 million and Free Cash Flow of $215 million to $235 million. Concentra also declared a cash dividend of $0.0625 per share, payable in June, and announced a $15 million share repurchase in Q1.

•5mo ago